Amedeo Smart

Free Medical Literature Service


 

Amedeo

Breast Cancer

  Free Subscription

Articles published in
Lancet
    August 2017
  1. MAMOUNAS EP, Kuehn T, Rutgers EJT, von Minckwitz G, et al
    Current approach of the axilla in patients with early-stage breast cancer.
    Lancet. 2017 Aug 14. pii: S0140-6736(17)31451.
    >> Share

  2. COLES CE, Griffin CL, Kirby AM, Titley J, et al
    Partial-breast radiotherapy after breast conservation surgery for patients with early breast cancer (UK IMPORT LOW trial): 5-year results from a multicentre, randomised, controlled, phase 3, non-inferiority trial.
    Lancet. 2017 Aug 2. pii: S0140-6736(17)31145.
    >> Share

  3. JAGSI R
    Early-stage breast cancer: falling risks and emerging options.
    Lancet. 2017 Aug 2. pii: S0140-6736(17)31599.
    >> Share

    June 2017
  4. THE LANCET
    Breast cancer targeted therapy: successes and challenges.
    Lancet. 2017;389:2350.
    >> Share

    February 2017
  5. CAMERON D, Piccart-Gebhart MJ, Gelber RD, Procter M, et al
    11 years' follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive early breast cancer: final analysis of the HERceptin Adjuvant (HERA) trial.
    Lancet. 2017 Feb 16. pii: S0140-6736(16)32616.
    >> Share

  6. SPECHT JM, Davidson NE
    Optimal duration of trastuzumab for early HER2-positive breast cancer.
    Lancet. 2017 Feb 16. pii: S0140-6736(17)30322.
    >> Share

    January 2017
  7. THE LANCET
    Trastuzumab emtansine and cost-based decision making.
    Lancet. 2017;389:2.
    >> Share

    November 2016
  8. CRISTOFANILLI M
    Metastatic breast cancer: focus on endocrine sensitivity.
    Lancet. 2016 Nov 28. pii: S0140-6736(16)32418.
    >> Share

  9. ROBERTSON JF, Bondarenko IM, Trishkina E, Dvorkin M, et al
    Fulvestrant 500 mg versus anastrozole 1 mg for hormone receptor-positive advanced breast cancer (FALCON): an international, randomised, double-blind, phase 3 trial.
    Lancet. 2016 Nov 28. pii: S0140-6736(16)32389.
    >> Share

  10. HARBECK N, Gnant M
    Breast cancer.
    Lancet. 2016 Nov 16. pii: S0140-6736(16)31891.
    >> Share

    September 2016
  11. THE LANCET
    Balancing the benefits and risks of choice.
    Lancet. 2016;388:1129.
    >> Share

    June 2016
  12. OHUCHI N, Suzuki A, Yamamoto S, Kuriyama S, et al
    Adjunctive ultrasonography for breast cancer screening - Authors' reply.
    Lancet. 2016;387:2381-2.
    >> Share

  13. AUTIER P, Boniol M
    Adjunctive ultrasonography for breast cancer screening.
    Lancet. 2016;387:2380.
    >> Share

  14. FUJITA T
    Adjunctive ultrasonography for breast cancer screening.
    Lancet. 2016;387:2380-1.
    >> Share

  15. DALE A, Slade E, Heneghan C
    Adjunctive ultrasonography for breast cancer screening.
    Lancet. 2016;387:2379-80.
    >> Share

    May 2016
  16. BERNSTEIN M
    Intraoperative radiation therapy for breast cancer: a patient's view.
    Lancet. 2016;387:1904-5.
    >> Share

    April 2016
  17. STRNAD V, Uter W, Polgar C
    Partial breast irradiation and the GEC-ESTRO trial - Authors' reply.
    Lancet. 2016;387:1718-9.
    >> Share

  18. VICINI F, Shah C, Arthur D, Khan A, et al
    Partial breast irradiation and the GEC-ESTRO trial.
    Lancet. 2016;387:1717-8.
    >> Share

  19. VAIDYA JS, Bulsara M, Wenz F, Tobias JS, et al
    Partial breast irradiation and the GEC-ESTRO trial.
    Lancet. 2016;387:1717.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016